# Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

> **NCT00123279** · PHASE2 · COMPLETED · sponsor: **ThromboGenics** · enrollment: 60 (actual)

## Conditions studied

- Vitreomacular Traction Maculopathy
- Eye Diseases

## Interventions

- **DRUG:** Microplasmin

## Key facts

- **NCT ID:** NCT00123279
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-02
- **Final completion:** 2008-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123279, "Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00123279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*